Qube Research & Technologies (QRT)
FPRX

Qube Research & Technologies (QRT)’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,203
Closed -$68K – 2267
2020
Q2 		$68K Buy
+11,203
New +$46.1K ﹤0.01% 1565

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FPRX Position: Q3 2020 in Review

Qube Research & Technologies (QRT) sold out of Five Prime Therapeutics, Inc. (FPRX) in Q3 2020, closing a stake of 11,203 shares — an estimated $68K sold.

Qube Research & Technologies (QRT) first reported a position in FPRX in Q2 2020 and held it in 1 quarter. The position peaked at $68K in Q2 2020. 94 funds tracked by Wall St. Rank hold FPRX as of Q3 2020.

  • Qube Research & Technologies (QRT) reported no remaining Five Prime Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 11,203 Five Prime Therapeutics, Inc. shares in Q3 2020, an estimated $68K.
  • Qube Research & Technologies (QRT) first reported a position in Five Prime Therapeutics, Inc. in Q2 2020 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Five Prime Therapeutics, Inc. position peaked at $68K in Q2 2020.
  • 94 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2020, filed 12 Nov 2020.